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àside1ALGORITHM FOR APPROPRIATE USE OF NEUROLEPTICS IN DEMENTIA
Anxiety, aggression or psychotic symptoms 
present in resident with dementia
Rule out 
u medical causes  u environmental causes  u psychosocial stresses. (see Box A: side 2)
Treat medical causes
Use behavioural and environmental interventions  
and supportive approaches. (see Box B: side 2)
Does the behaviour warrant psychotropic drug use?
à
Anxiety: (including panic disorder or generalized 
anxiety disorder)
Document indications in progress notes, then
treat with a short-acting anxiolytic:
• Aim to give lowest dose for shortest duration
• Combine pharmacological and behavioural,
environmental interventions
• Attempt gradual dosage reduction 
(e.g. 10 - 25%) when there is an improvement 
in or resolution of target behaviour
• Continue with dosage reduction if 
target behaviours do not return on the 
reduced dosage.
• Limit daily use to less than 4 months unless 
gradual dosage reduction is unsuccessful
• Carefully monitor for sedation
Appropriate indications
The behaviour is persistent, documented, and 
characterized by one of the following:
1. psychotic symptoms
2. danger to self or others
3. continuous crying, screaming, or yelling or pacing to the
point of interference with the ability to receive care
Is behaviour primarily 
characterized by 
anxiety, aggression or 
psychotic symptoms?Document indications in progress notes, then treat with a neuroleptic
• Aim to give lowest dose for shortest duration
• Combine pharmacological and behavioural, environmental interventions
• Routine administration preferable to PRN
• Use PRN treatment only if:
1. titrating dosage up  
2. managing anticipated episodes of harmful behaviours that can
not be managed in other ways
• Attempt gradual dosage reduction (e.g. 10 - 25%) when there is an 
improvement in or resolution of target behaviour
• Continue with dosage reduction if target behaviours do not return on 
the reduced dosage.
• Attempt and document dose reductions and/or drug holidays at least 
every six months.
• Carefully monitor for side effects:
– Sedation, and Orthostatic hypotension
– Anticholinerigic effects (constipation, blurred vision, urinary 
retention, dry mouth)
– EPS extrapyramidal effects (muscle spasms or dystonia: rigidity 
or parkinsonism: restlessness or akathisia)
– TD tardive dyskinesia (involuntary movement of lips, tongue,
limbs: difficulty swallowing)
à
à
à
à
no àyes
• Depression without psychosis
• Fidgeting/nervousness
• Restlessness/pacing
• Indifference to surroundings
à
Aggression or Psychotic symptoms
Anxiety
à
Developed by Neuroleptic Study Steering Committee (2002)     
Inappropriate indications
• Wandering
• Insomnia
• Unsociability
• Poor self care
• Impaired memory
Use behavioural and environmental interventions
and supportive approaches. (see Box B: side 2)
ALGORITHM FOR APPROPRIATE USE OF NEUROLEPTICS IN DEMENTIA side2
Highlights of research on 
neuroleptics for treatment of
behavioural and psychological
symptoms of dementia
n Efficacy of neuroleptics for most 
of these behaviours is quite low.
In several studies, the drugs have 
been no more effective than placebo
n Newer agents (atypicals) appear to 
have advantages over traditional 
neuroleptics (e.g. less risk of EPS)
n Limited evidence supports use of 
SSRI’s or trazodone
n EPS, particularly akathisia, which 
causes pacing, restlessness and 
inability to sit still, may be mistaken 
for agitation: akathisia often appears 
with initiation of neuroleptic 
medications
Definitions
Anxiety
Observable, excessive, physical
and/or verbal activity associated
with a feeling of inner tension,
frustration or stresses that 
overwhelm a person
Aggression
Physical and/or verbal behaviours
that pose a threat of harm to 
self or others.
Psychotic symptoms 
Delusions: false beliefs
Hallucinations: false perceptions
Occur in 30 - 50% of persons 
with dementia
Box A
Examples of medical or environmental causes and psychosocial stressors:
• Delirium
• Pain
• Infections 
• Constipation 
• Depression 
• Sleep disorders
• Drug Reactions: drug-drug 
interactions
• Loss of control of chronic illness
• Disorientation
• Changes in routine 
• Boredom; lack of stimuli
• Impairment of vision or hearing
• Loss of personal space
• Inadequate or excessive heat, cold,
noise, lighting
Rule out 
u medical causes  u environmental causes  u psychosocial stresses.
Box B
Examples of behavioural / environmental interventions and supportive approaches:
• Family and friends involvement
• Team consistency 
• Music therapy
• Pet therapy
• Reminiscence
• Validation
Use behavioural and environmental interventions
and supportive approaches.
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• Reality orienting
• Privacy
• Familiar objects
• Meaningful activities
• Adapting environmental stimuli 
(e.g. reducing noise)
u
u
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